BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 2568971)

  • 21. Nizatidine versus ranitidine in gastric ulcer disease. A European multicentre trial.
    Naccaratto R; Cremer M; Dammann HG; Keohane PP; Mulder H; Sarles H; Simon B
    Scand J Gastroenterol Suppl; 1987; 136():71-8. PubMed ID: 2892258
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of nizatidine and cimetidine on betazole-stimulated gastric secretion of normal subjects: comparison of effects on acid, water, and pepsin.
    Hammond JB; Offen WW
    Am J Gastroenterol; 1988 Jan; 83(1):32-6. PubMed ID: 2892392
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative study of the H2-receptor antagonists cimetidine, ranitidine, famotidine and nizatidine on the rabbit stomach fundus and sigmoid colon.
    Kounenis G; Koutsoviti-Papadopoulou M; Elezoglou A; Voutsas A
    J Pharmacobiodyn; 1992 Oct; 15(10):561-5. PubMed ID: 1362967
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 300 mg nizatidine at night versus 300 mg ranitidine at night in patients with duodenal ulcer. A multicentre trial in Europe.
    Simon B; Cremer M; Dammann HG; Hentschel E; Keohane PP; Mulder H; Müller P; Sarles H
    Scand J Gastroenterol Suppl; 1987; 136():61-70. PubMed ID: 2892257
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Random double-blind comparison of nizatidine, famotidine, ranitidine and placebo.
    McAllister JD; Moote CA; Sharpe MD; Manninen PH
    Can J Anaesth; 1990 May; 37(4 Pt 2):S22. PubMed ID: 1972914
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of H2-receptor antagonists on gastric alcohol dehydrogenase activity.
    Caballería J; Baraona E; Deulofeu R; Hernández-Muñoz R; Rodés J; Lieber CS
    Dig Dis Sci; 1991 Dec; 36(12):1673-9. PubMed ID: 1684149
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of ranitidine and cimetidine on the twenty-four hour intragastric acidity profile and nocturnal acid secretion in duodenal ulcer patients.
    Walt RP; Malé PJ; Hunt RH; Rawlings J; Milton-Thompson GJ; Misiewicz JJ
    Scand J Gastroenterol Suppl; 1981 Jun; 69():33-7. PubMed ID: 6119780
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of intragastric acidity in healthy subjects dosed with ranitidine 75 mg: a comparative study with cimetidine and placebo.
    Grimley CE; Constantinides S; Snell CC; Mills JG; Nwokolo CU
    Aliment Pharmacol Ther; 1997 Oct; 11(5):875-9. PubMed ID: 9354195
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effects of various histamine H2-receptor antagonists on gastrointestinal motility and gastric emptying].
    Ohira Y; Hanyu N; Aoki T; Hashimoto Y; Iikura M; Fukuda S
    J Smooth Muscle Res; 1993 Aug; 29(4):131-42. PubMed ID: 7907895
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rebound nocturnal hypersecretion after four weeks treatment with an H2 receptor antagonist.
    Fullarton GM; McLauchlan G; Macdonald A; Crean GP; McColl KE
    Gut; 1989 Apr; 30(4):449-54. PubMed ID: 2565860
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of 800 mg cimetidine once daily on gastric acid secretion.
    Dammann HG; Walter TA; Mueller P; Simon B
    Scand J Gastroenterol Suppl; 1986; 121():25-9. PubMed ID: 3532295
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of famotidine with cimetidine and ranitidine.
    Berardi RR; Tankanow RM; Nostrant TT
    Clin Pharm; 1988 Apr; 7(4):271-84. PubMed ID: 2896559
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of roxatidine acetate on 24-hour intragastric acidity. Investigations in healthy volunteers and comparison with ranitidine and placebo.
    Merki HS; Witzel L; Kaufmann D; Kempf M; Neumann J; Scheurle E; Röhmel J; Walt RP
    Drugs; 1988; 35 Suppl 3():69-75. PubMed ID: 2905252
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Single nocturnal dose of an H2 receptor antagonist for the treatment of duodenal ulcer.
    Gledhill T; Howard OM; Buck M; Paul A; Hunt RH
    Gut; 1983 Oct; 24(10):904-8. PubMed ID: 6311692
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the effect of the antacid Rennie versus low-dose H2-receptor antagonists (ranitidine, famotidine) on intragastric acidity.
    Netzer P; Brabetz-Höfliger A; Bründler R; Flogerzi B; Hüsler J; Halter F
    Aliment Pharmacol Ther; 1998 Apr; 12(4):337-42. PubMed ID: 9690722
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics and pharmacodynamics of oral nizatidine.
    Vargas R; Ryan J; McMahon FG; Regel G; Offen WW; Matsumoto C
    J Clin Pharmacol; 1988 Jan; 28(1):71-5. PubMed ID: 2895125
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decrease of intragastric acidity in healthy subjects dosed with ranitidine 75 mg, cimetidine 200 mg, or placebo.
    Hamilton MI; Sercombe J; Pounder RE
    Dig Dis Sci; 2002 Jan; 47(1):54-7. PubMed ID: 11837732
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lack of effect of nizatidine on drug metabolism.
    Klotz U
    Scand J Gastroenterol Suppl; 1987; 136():18-23. PubMed ID: 2892251
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 24 hour intragastric acidity and single night-time dose of three H-2-blockers.
    Dammann HG; Müller P; Simon B
    Lancet; 1983 Nov; 2(8358):1078. PubMed ID: 6138616
    [No Abstract]   [Full Text] [Related]  

  • 40. [Treatment of acute stomach ulcer with H2 receptor antagonists. A direct therapy comparison with 300 mg nizatidine nightly and 2 times 150 mg nizatidine with twice daily 150 mg ranitidine].
    Arnold R; Beckenbach P; Bock H; Bormann R; Brunner G; Daake H; Dammann HG; Dietrich K; Fuerer M; Geiter B
    Fortschr Med; 1989 Jun; 107(17):390-4. PubMed ID: 2568327
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.